Diseases, Conditions, Syndromes

Trials of novel Ebola drugs to be fast-tracked in West Africa

Potential new treatments for Ebola are to be tested in West Africa for the first time as part of an international initiative to fast-track trials of the most promising drugs against the disease that has already led to over ...

Diseases, Conditions, Syndromes

Societal challenges and new treatments for Ebola virus disease

Since Ebola was first described in 1976, there have been several outbreaks, but all have been self-limiting. In a new Journal of Internal Medicine review, Dr. Ali Mirazimi of the Karolinska Institutet considers why the latest ...

Diseases, Conditions, Syndromes

Modified malaria drug proven effective at inhibiting Ebola

Robert Davey, professor of microbiology at Boston University School of Medicine and researcher at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), in collaboration with researchers at Nagasaki ...

Diseases, Conditions, Syndromes

Experimental Ebola vaccines elicit year-long immune response

Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...

Diseases, Conditions, Syndromes

Ebola survivors suffer from severe neurological problems

Researchers have shed new light on the psychiatric and neurological problems that Ebola survivors can suffer from, and call for more specialist support for the most severely affected patients.

Diseases, Conditions, Syndromes

What drives Ebola

As the deadly disease attacks West Africa, a Tufts expert in the virus explains its origins and ecology and the best ways to fight its spread.

Diseases, Conditions, Syndromes

Study sheds light on Dengue immune response

India suffers from the highest number of dengue infections in the world, but there are few studies, if any, to understand the immune cells involved in fighting the virus.

page 8 from 28